Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C
about
Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidneyTenascin-C and integrins in cancerMolecular cloning of POEM: a novel adhesion molecule that interacts with alpha8beta1 integrinThe ECM protein nephronectin promotes kidney development via integrin alpha8beta1-mediated stimulation of Gdnf expressionIdentification of a gene regulatory network associated with prion replication.Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix moleculesIncreased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas.Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer.Gene expression profiles of hepatoma cell line HLE.Integrin gene expression profiles of human hepatocellular carcinomaMethods for identifying novel integrin ligandsOsteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.Tensegrin in context: Dual role of α8 integrin in the migration of different cell typesExtracellular matrix signaling in morphogenesis and repair.Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis.The role of tenascin-C in tissue injury and tumorigenesis.Functional characterization of integrin alpha6beta4 adhesion interactions using soluble integrin constructs reveals the involvement of different functional domains in the beta4 subunit.Production of recombinant soluble human integrin alpha4beta1.Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells.Generation of a minimal alpha5beta1 integrin-Fc fragment.Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2.
P2860
Q24291483-A88F1C76-DCD3-4F4A-8A9D-ED33434D5E94Q28082328-8FC55566-FFE8-4FF0-AC24-24AED8E34107Q28506150-747E2C55-3738-42F4-835C-294AF3F47214Q28589474-3836BCC6-ECD3-4510-BAE2-BC6993846660Q30458186-D820D626-22C8-4264-A1A9-B28C4129C685Q33904614-35A153A8-F282-4C83-AA36-37673BEA8147Q34098674-37A8A41C-AAE9-404A-BFA2-4CE5F488DAAFQ34616118-F57388DC-09BF-41CF-A000-59C39D8D828DQ36178624-6C150455-8659-4191-BE9A-59B37F4690E9Q36308179-F7277016-6A5D-47B2-A5CB-7E41B8C1A2CFQ36909821-A3018E96-60EC-4F4B-872D-96544F536E77Q37549558-0330B34B-4E72-410C-9D4F-D4BE88F77385Q37575786-1ACF7B36-EDF8-4642-905E-3CB8285CC574Q37764646-B1142EC5-C022-459D-BC0E-D487444A56F3Q38111039-54F507C2-DD86-44F7-9DED-E019056D04D8Q38611613-E3E6933A-B4B4-4EC0-9ED9-82E0F89B403DQ39280466-0C2BADD8-C0D3-479F-89DD-52A29310CE98Q39922248-EAACB5F7-E4DD-4C5E-9DE4-D643C5BA75C6Q40886543-3F4B01D7-E856-4F32-A07D-4C21D07C57DAQ42574585-B880D764-66A7-4357-969B-575A5D8A6C44Q43627902-5504671D-E7EC-4157-B523-32BBD1F48459Q44219945-E41BDD4D-B7A8-4F4F-ADF9-DB5F08374CE2Q48283056-E80797FD-764C-4E5A-98C5-F871D3C63E4E
P2860
Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Utilization of a soluble integ ...... , but not to native tenascin-C
@ast
Utilization of a soluble integ ...... , but not to native tenascin-C
@en
Utilization of a soluble integ ...... , but not to native tenascin-C
@nl
type
label
Utilization of a soluble integ ...... , but not to native tenascin-C
@ast
Utilization of a soluble integ ...... , but not to native tenascin-C
@en
Utilization of a soluble integ ...... , but not to native tenascin-C
@nl
prefLabel
Utilization of a soluble integ ...... , but not to native tenascin-C
@ast
Utilization of a soluble integ ...... , but not to native tenascin-C
@en
Utilization of a soluble integ ...... , but not to native tenascin-C
@nl
P2093
P2860
P356
P1433
P1476
Utilization of a soluble integ ...... , but not to native tenascin-C
@en
P2093
H P Erickson
K L Crossin
L F Reichardt
P2860
P304
P356
10.1021/BI9727489
P407
P577
1998-04-21T00:00:00Z